Microvast’s Q2 2024 Revenue Surges to $83.7Mby Mark Eisenberg 10.08.2024Microvast reports record Q2 2024 revenue at $83.7M, up 12%. Gross margin hits 32.5% amid EMEA sales boost, despite challenges.
Solana Emerges Victorious Over Ethereum in Crypto Battleby John Darbie 10.08.2024Analysis shows Solana's strengths over Ethereum. Solana's speed and cost effectiveness lead to its advantage.
Kamala Harris Picks Tim Walz, Spotlight on Progressive Economicsby Mark Eisenberg 09.08.2024Harris selects Walz as VP, highlighting progressive economics in upcoming election. Focus on government oversight and worker protection.
Rocket Lab’s Q2 Revenue Climbs 71%, Hits $106Mby Mark Eisenberg 09.08.2024Rocket Lab's Q2 revenue surged 71%, reaching $106M, driven by Electron rocket's successes and Neutron's development progress.
Dogecoin Whales Shift Focus to Mpeppe: Price Surge Ahead?by John Darbie 09.08.2024Dogecoin whales invest in Mpeppe, hinting at a potential price surge. Explore why this new coin is attracting major attention.
Dogecoin, AAVE, and DTX Lead Crypto Marketby John Darbie 09.08.2024Explore Dogecoin, AAVE, and DTX's unique growth potential amid crypto market shifts.
PLBY Group Unveils Q2 2024 Results and Future Plansby Mark Eisenberg 09.08.2024PLBY Group discusses earnings, new deals, and magazine revival for Q2 2024.
Green Dot Sees Growth with Compliance Focusby Mark Eisenberg 09.08.2024Green Dot forecasts growth despite compliance costs, sees B2B as key to future expansion.
Novavax Q2 2024: Sanofi Deal Boosts Revenueby Mark Eisenberg 09.08.2024Novavax reports $415M in Q2 revenue with Sanofi's help, eyeing new vaccine launches and cost reductions.
Crypto Analyst Predicts 450% Surge for XRPby John Darbie 09.08.2024Analyst sees XRP skyrocketing post-SEC settlement, updates Bitcoin and Ethereum forecasts.